CEPHX- Cephalometric Analysis Software

CEPHX - Cephalometric Analysis Software utilizes artificial intelligence to automatically detect 99 landmarks on 2D cephalometric x-ray images, providing dentists with a tool for orthodontic image analysis, diagnosis, and treatment planning simulation. The system aims to enhance clinical workflow by offering automated landmarking and analytical reports, with its performance validated by achieving 99% accuracy in landmark identification within a 2.0mm margin compared to specialist orthodontists.

CEPHX - Cephalometric Analysis Software is a medical imaging software designed to assist dentists providing orthodontic treatment. Its primary purpose is to facilitate image analysis, treatment simulation, profilogram creation, Visual Treatment Objective (VTO) generation, and patient consultation. The software operates by processing 2D cephalometric x-ray images uploaded by the user. Utilizing artificial intelligence, it automatically generates 99 cephalometric landmark points on these images. These landmarks, which are crucial points on a lateral radiographic view of the teeth, jaws, and skull base, form the basis for various cephalometric analyses, aiding in the diagnosis of facial abnormalities and planning orthodontic interventions. Dentists can then generate comprehensive reports using a selection of built-in analysis methods or by creating custom analyses through an "Analysis Wizard." The software is intended for use by qualified and trained dentists as a supportive tool; the diagnostic and treatment planning results derived from it are explicitly dependent on the professional interpretation of these licensed practitioners. It is indicated for patients aged 14 years and older. Performance data from a verification study demonstrated the software's accuracy in landmark detection. In this study, AI-generated landmarks were compared against those manually identified by three orthodontic specialists. The results showed that 99% of 21 clinically significant landmarks were identified by the AI within a 2.0mm "pass" margin compared to the specialists' consensus, meeting predefined accuracy endpoints and supporting its reliability for clinical support.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific AI algorithms or machine learning models are employed for the automated detection of the 99 cephalometric landmarks, and how were these models trained and validated beyond the described study?; How does the software's performance vary across different qualities of cephalometric images (e.g., images with noise, artifacts, or poor contrast) or in patients with significant craniofacial anomalies?; The study mentions 21 clinically significant landmarks were compared with a 2.0mm "pass" margin. How were these 21 landmarks selected from the 99 generated, and what is the clinical significance of the 2.0mm threshold for orthodontic decision-making?; Beyond landmark identification, what is the extent and accuracy of the "simulation" and "Visual Treatment Objective (VTO)" features, and how do these compare to manual prediction methods or other VTO software?; Given the software is a supporting tool, what guidance or training is provided to dentists to ensure they correctly interpret the AI-generated landmarks and subsequent analyses, especially in cases where the AI might deviate from typical presentations?